HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramin Tadayoni Selected Research

Takayasu Arteritis (Arteritis, Takayasu's)

10/2021Correlation between Ultra-Wide-Field Retinal Imaging Findings and Vascular Supra-Aortic Changes in Takayasu Arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramin Tadayoni Research Topics

Disease

24Macular Edema
04/2024 - 02/2003
24Macular Degeneration (Age-Related Maculopathy)
02/2024 - 09/2009
18Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 02/2003
9Retinal Detachment (Retinal Detachments)
02/2024 - 01/2011
9Retinal Vein Occlusion
01/2024 - 11/2014
8Inflammation (Inflammations)
10/2023 - 01/2011
8Choroidal Neovascularization
02/2023 - 09/2009
7Retinal Perforations
01/2024 - 12/2012
6Central Serous Chorioretinopathy
05/2023 - 01/2019
6Epiretinal Membrane (Epiretinal Membranes)
11/2022 - 01/2011
6Vascular Diseases (Vascular Disease)
01/2022 - 03/2015
5Retinal Diseases
07/2023 - 01/2014
4Vision Disorders (Hemeralopia)
02/2024 - 03/2015
4Telangiectasis (Telangiectasia)
01/2023 - 07/2014
4Ischemia
01/2022 - 01/2016
4Cataract (Cataracts)
06/2020 - 02/2003
3Hemorrhage
01/2023 - 09/2012
3Atrophy
01/2020 - 09/2012
3Edema (Dropsy)
12/2019 - 02/2003
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
12/2018 - 02/2012
3Vitreous Detachment (Posterior Vitreous Detachment)
01/2018 - 03/2003
2CADASIL
01/2024 - 01/2023
2Geographic Atrophy
10/2023 - 08/2010
2Retinal Telangiectasis
01/2023 - 08/2010
2Retinal Vasculitis
01/2023 - 01/2021
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018 - 10/2009
2Epilepsy (Aura)
01/2017 - 12/2016
2Uveitis
03/2016 - 01/2014
1Disease Progression
10/2023
1Vasculitis (Vasculitides)
10/2023
1Exfoliative Dermatitis (Erythroderma)
05/2023
1Dry Eye Syndromes (Dry Eye Syndrome)
05/2023
1Acquired Immunodeficiency Syndrome (AIDS)
05/2023
1Choroidal Effusions
05/2023
1Conjunctivitis
05/2023
1Atopic Dermatitis (Atopic Eczema)
05/2023
1Stroke (Strokes)
01/2023
1Retinoschisis (Retinoschisis, Juvenile)
12/2022
1Dehydration (Water Stress)
11/2022
1Polypoidal Choroidal Vasculopathy
11/2022
1Low Vision (Subnormal Vision)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Retinal Arterial Macroaneurysm
12/2021
1Takayasu Arteritis (Arteritis, Takayasu's)
10/2021
1Aortic Valve Stenosis (Aortic Stenosis)
10/2021
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2021
1Endophthalmitis (Ophthalmia)
01/2021
1Pituitary Neoplasms (Pituitary Adenoma)
08/2020
1Ganglion Cysts (Ganglion)
08/2020
1Polyps
01/2020
1Chalazion
01/2020
1Critical Illness (Critically Ill)
01/2020
1COVID-19
01/2020

Drug/Important Bio-Agent (IBA)

47Retinaldehyde (Retinal)IBA
02/2024 - 10/2003
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024 - 01/2014
14afliberceptIBA
01/2024 - 03/2020
14Ranibizumab (Lucentis)FDA Link
10/2023 - 09/2009
13Fluorescein (Funduscein)FDA LinkGeneric
01/2024 - 02/2003
9brolucizumabIBA
10/2023 - 01/2021
6Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 11/2014
5DystrophinIBA
01/2019 - 02/2012
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2023 - 01/2020
3Retinal Pigments (Pigments, Visual)IBA
01/2020 - 09/2012
2faricimabIBA
02/2024 - 01/2024
2Biomarkers (Surrogate Marker)IBA
01/2024 - 09/2023
2Vascular Endothelial Growth FactorsIBA
10/2023 - 01/2021
2Biosimilar PharmaceuticalsIBA
07/2023 - 06/2022
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2023 - 12/2021
2Mineralocorticoid Receptor AntagonistsIBA
01/2019 - 01/2019
2N-acetyltryptophanamide (NATA)IBA
12/2017 - 01/2016
2Proteins (Proteins, Gene)FDA Link
05/2016 - 01/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
04/2024
1Angiopoietin-2IBA
01/2024
1salicylhydroxamic acid (SHAM)IBA
10/2023
1PlacebosIBA
10/2023
1dupilumabIBA
05/2023
1SuspensionsIBA
02/2023
1peginterferon alfa-2a (Pegasys)FDA Link
01/2023
1Interferon alpha-2 (Roferon-A)FDA Link
01/2023
1SteroidsIBA
01/2023
1Angiogenesis InhibitorsIBA
01/2023
1ORALIT (ORS)IBA
12/2022
11-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022
1Verteporfin (Visudyne)FDA Link
11/2022
1Capsules (Microcapsules)IBA
06/2020
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2020
1Glutamic Acid (Glutamate)FDA Link
01/2020
1BradykininIBA
01/2020

Therapy/Procedure

12Therapeutics
12/2023 - 09/2012
8Vitrectomy
01/2023 - 03/2003
7Lasers (Laser)
12/2017 - 12/2012
5Injections
01/2022 - 09/2009
5Intravitreal Injections
01/2020 - 02/2003
5Light Coagulation
01/2018 - 10/2009
4Traction
11/2022 - 01/2018
4Aftercare (After-Treatment)
10/2022 - 01/2015
2Slit Lamp
07/2014 - 01/2014
1Biological Therapy
06/2022
1Critical Care (Surgical Intensive Care)
01/2020